BIOLASE to Present at Canaccord Genuity 2012 Medical Technology & Diagnostics Forum
(firmenpresse) - IRVINE, CA -- (Marketwire) -- 11/26/12 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that Fred Furry, Chief Operating Officer and Chief Financial Officer, is scheduled to present at the Canaccord Genuity 2012 Medical Technology & Diagnostics Forum as follows:
Date: Tuesday, December 4
Time: 4:00 pm Eastern Standard Time
Location: Le Parker Meridien, New York, NY
Live audio webcast: under "" or
Following its completion, a replay of the presentation will be available through December 18, 2012, on BIOLASE's website at under the "Investors" section.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets and also distributes and markets dental ; products that are focused on technologies that advance the practice of dentistry and . The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 20,600 lasers. Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at , Facebook at , Twitter at , and YouTube at .
For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.11.2012 - 21:51 Uhr
Sprache: Deutsch
News-ID 206748
Anzahl Zeichen: 0
contact information:
Town:
IRVINE, CA
Kategorie:
Equipment & Supplies
Diese Pressemitteilung wurde bisher 185 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BIOLASE to Present at Canaccord Genuity 2012 Medical Technology & Diagnostics Forum"
steht unter der journalistisch-redaktionellen Verantwortung von
BIOLASE, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
